• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胆固醇与冠心病:通过水平及比率变化预测男性风险

Cholesterol and coronary heart disease: predicting risks in men by changes in levels and ratios.

作者信息

Kinosian B, Glick H, Preiss L, Puder K L

机构信息

University of Pennsylvania, Philadelphia 19104, USA.

出版信息

J Investig Med. 1995 Oct;43(5):443-50.

PMID:8528755
Abstract

BACKGROUND

Little is known about the relative ability of different measures of change in cholesterol to discriminate coronary heart disease risk. We evaluated this ability for changes in low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, LDL/HDL ratios, and total cholesterol/HDL ratios.

METHODS

We predicted risks of coronary heart disease using data from 3641 men in the Lipid Research Clinics Coronary Primary Prevention Trial. Treating these patients as a cohort, we estimated risks associated with changes in cholesterol levels independent of the patients' randomization group.

RESULTS

Changes in LDL and HDL cholesterol when used in combination were each significant predictors of coronary heart disease risk (odds ratios [OR] for 10% increases, 1.15 and 0.84, respectively; P < 0.001). Changes in LDL/HDL and total cholesterol/HDL ratios had similar discriminating ability (OR for 10% increases, 1.17 and 1.21, respectively; P < 0.0001). In the best discriminating models, changes in ratios added information about risks to changes in LDL cholesterol, although changes in LDL cholesterol levels failed to add information to changes in ratios.

CONCLUSIONS

Changes in total cholesterol/HDL and LDL/HDL ratios were better predictors of risk for coronary heart disease than were changes in LDL cholesterol levels alone. When assessed as percentage changes averaged during the first two months of intervention, they were among the best discriminators of risk. Clinicians selecting treatments for intervention should include among their considerations the treatment's effect on both LDL and HDL cholesterol rather than their effects on LDL cholesterol levels alone.

摘要

背景

关于胆固醇变化的不同测量指标区分冠心病风险的相对能力,人们了解甚少。我们评估了低密度脂蛋白(LDL)胆固醇、高密度脂蛋白(HDL)胆固醇、LDL/HDL比值和总胆固醇/HDL比值变化的这种能力。

方法

我们使用脂质研究临床冠心病一级预防试验中3641名男性的数据预测冠心病风险。将这些患者视为一个队列,我们估计了与胆固醇水平变化相关的风险,而不考虑患者的随机分组。

结果

LDL和HDL胆固醇变化联合使用时,均是冠心病风险的显著预测指标(10%升高的比值比[OR]分别为1.15和0.84;P<0.001)。LDL/HDL和总胆固醇/HDL比值变化具有相似的区分能力(10%升高的OR分别为1.17和1.21;P<0.0001)。在最佳区分模型中,比值变化为LDL胆固醇变化的风险信息增添了内容,尽管LDL胆固醇水平变化未能为比值变化增添信息。

结论

总胆固醇/HDL和LDL/HDL比值变化比单独的LDL胆固醇水平变化更能预测冠心病风险。当作为干预前两个月的平均百分比变化进行评估时,它们是风险的最佳区分指标之一。选择干预治疗的临床医生应将治疗对LDL和HDL胆固醇的影响而非仅对LDL胆固醇水平的影响纳入考虑。

相似文献

1
Cholesterol and coronary heart disease: predicting risks in men by changes in levels and ratios.胆固醇与冠心病:通过水平及比率变化预测男性风险
J Investig Med. 1995 Oct;43(5):443-50.
2
Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial.在退伍军人事务部高密度脂蛋白干预试验中,低密度脂蛋白和高密度脂蛋白颗粒亚类可预测冠状动脉事件,并且吉非贝齐治疗可使其发生有利变化。
Circulation. 2006 Mar 28;113(12):1556-63. doi: 10.1161/CIRCULATIONAHA.105.565135. Epub 2006 Mar 13.
3
Lability of serum low-density lipoprotein cholesterol levels during screening in subgroup of Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) cohort.空军/德克萨斯冠状动脉粥样硬化预防研究(AFCAPS/TexCAPS)队列亚组筛查期间血清低密度脂蛋白胆固醇水平的不稳定性。
J Am Osteopath Assoc. 2002 Jul;102(7):377-84.
4
Correlates and consequences of diffuse atherosclerosis in men with coronary heart disease. Veterans Affairs High-Density Lipoprotein Intervention Trial Study Group.冠心病男性患者弥漫性动脉粥样硬化的相关因素及后果。退伍军人事务部高密度脂蛋白干预试验研究组。
Arch Intern Med. 1996 Jun 10;156(11):1181-8.
5
Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).冠心病患者中提高高密度脂蛋白胆固醇的临床获益与血清低密度脂蛋白胆固醇水平的关系(来自苯扎贝特预防心肌梗死试验)
Am J Cardiol. 2009 Jan 1;103(1):41-5. doi: 10.1016/j.amjcard.2008.08.033. Epub 2008 Oct 10.
6
Search for an optimal atherogenic lipid risk profile: from the Framingham Study.寻找最佳动脉粥样硬化性脂质风险谱:来自弗雷明汉姆研究。
Am J Cardiol. 2006 Feb 1;97(3):372-5. doi: 10.1016/j.amjcard.2005.08.055.
7
Non-high-density lipoprotein cholesterol in secondary prevention of coronary artery disease: a unique risk factor or redundant information?非高密度脂蛋白胆固醇在冠状动脉疾病二级预防中的作用:一个独特的危险因素还是冗余信息?
J Cardiopulm Rehabil Prev. 2007 Nov-Dec;27(6):386-9. doi: 10.1097/01.HCR.0000300266.92516.6a.
8
Improving the prediction of cardiovascular risk: interaction between LDL and HDL cholesterol.改善心血管风险预测:低密度脂蛋白与高密度脂蛋白胆固醇之间的相互作用。
Epidemiology. 2003 May;14(3):315-20.
9
Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol.以高密度脂蛋白胆固醇水平低为特征的人群中血脂异常的风险判定
Am Heart J. 2003 Dec;146(6):1052-9. doi: 10.1016/S0002-8703(03)00516-7.
10
A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.一项为期52周的随机、开放标签、平行组比较研究,旨在观察匹伐他汀和阿托伐他汀对日本低密度脂蛋白胆固醇水平升高且伴有糖耐量异常患者的高密度脂蛋白胆固醇水平及糖代谢的耐受性和影响。
Clin Ther. 2008 Jun;30(6):1089-101. doi: 10.1016/j.clinthera.2008.05.017.

引用本文的文献

1
Manifestations of human atherosclerosis across vascular beds.人类动脉粥样硬化在不同血管床的表现。
JVS Vasc Insights. 2024;2. doi: 10.1016/j.jvsvi.2024.100089. Epub 2024 May 9.
2
A Narrative Review of the Role of Blood Biomarkers in the Risk Prediction of Cardiovascular Diseases.血液生物标志物在心血管疾病风险预测中作用的叙述性综述
Cureus. 2024 Dec 1;16(12):e74899. doi: 10.7759/cureus.74899. eCollection 2024 Dec.
3
A Systematic Review of Phytochemistry, Nutritional Composition, and Pharmacologic Application of Species of the Genus in Noncommunicable Diseases (NCDs).
关于该属物种在非传染性疾病(NCDs)中的植物化学、营养成分及药理应用的系统评价。
Evid Based Complement Alternat Med. 2023 Oct 31;2023:5406039. doi: 10.1155/2023/5406039. eCollection 2023.
4
The Role of Hemp ( L.) as a Functional Food in Vegetarian Nutrition.大麻(L.)作为功能性食品在素食营养中的作用。
Foods. 2023 Sep 20;12(18):3505. doi: 10.3390/foods12183505.
5
Early Contributors to Healthy Arterial Aging Versus Premature Atherosclerosis in Young Adults: The Bogalusa Heart Study.年轻成年人健康动脉老化与动脉粥样硬化过早发生的早期贡献者:博加卢萨心脏研究。
J Am Heart Assoc. 2021 Jun 15;10(12):e020774. doi: 10.1161/JAHA.121.020774. Epub 2021 Jun 5.
6
High fat diet altered cardiac metabolic gene profile in Psammomys obesus gerbils.高脂肪饮食改变沙鼠心脏代谢基因谱。
Lipids Health Dis. 2020 Jun 3;19(1):123. doi: 10.1186/s12944-020-01301-y.
7
Simple renal cysts are associated with increased arterial stiffness in a Taiwanese population.单纯性肾囊肿与台湾人群的动脉僵硬度增加有关。
Hypertens Res. 2019 Jul;42(7):1068-1073. doi: 10.1038/s41440-018-0202-6. Epub 2019 Jan 21.
8
Aspects of the parent-child relationship and parent metabolic outcomes.亲子关系的各个方面及其对父母代谢结果的影响。
J Behav Med. 2019 Apr;42(2):204-216. doi: 10.1007/s10865-018-9975-y. Epub 2018 Sep 27.
9
When anger expression might be beneficial for African Americans: The moderating role of chronic discrimination.当愤怒表达可能对非裔美国人有益时:慢性歧视的调节作用。
Cultur Divers Ethnic Minor Psychol. 2018 Jul;24(3):303-318. doi: 10.1037/cdp0000185. Epub 2018 May 24.
10
The effects of seed from Linum usitatissimum cultivar with increased phenylpropanoid compounds and hydrolysable tannin in a high cholesterol-fed rabbit.富含苯丙素化合物和可水解单宁的亚麻品种的种子对高胆固醇喂养的兔的影响。
Lipids Health Dis. 2018 Apr 10;17(1):76. doi: 10.1186/s12944-018-0726-4.